Safety of low-intensity extracorporeal shock wave therapy in prostate disorders: in vitro and in vivo evidence
Yiran Wang(The Fifth People’s Hospital of Suzhou), Zhiping Wang(Xuzhou Medical College)
Cited by 1
Related Papers
Application of a nanotechnology antimicrobial spray to prevent lower urinary tract infection: a multicenter urology trial
|Journal of Translational Medicine|2012|50
miR-541-3p enhances the radiosensitivity of prostate cancer cells by inhibiting HSP27 expression and downregulating β-catenin
|Cell Death Discovery|2021|40
The environmental endocrine disruptor p-nitrophenol interacts with FKBP51, a positive regulator of androgen receptor and inhibits androgen receptor signaling in human cells
|Journal of Hazardous Materials|2015|34